These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32735713)

  • 1. Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19.
    Herman A; Matthews M; Mairlot M; Nobile L; Fameree L; Jacquet LM; Baeck M
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e768-e700. PubMed ID: 32735713
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19.
    Ramirez GA; Della-Torre E; Tresoldi M; Scarpellini P; Ciceri F; Dagna L; Yacoub MR
    Clin Microbiol Infect; 2021 Aug; 27(8):1190-1192. PubMed ID: 34015530
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.
    Shiohara T; Mizukawa Y
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e98-e100. PubMed ID: 32970885
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?
    Balconi SN; Lopes NT; Luzzatto L; Bonamigo RR
    Int J Dermatol; 2021 Jan; 60(1):125-126. PubMed ID: 33231286
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system.
    Cucka B; Biglione B; Zhou L; Phillips EJ; Bassir F; Samarakoon U; Rrapi R; Chand S; Wang L; Alvarez-Arango S; Blumenthal KG; Kroshinsky D
    Br J Dermatol; 2022 Oct; 187(4):619-622. PubMed ID: 35700153
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications.
    Cheng J; Rawal S; Roberts A; Guttman OR
    Pediatr Infect Dis J; 2013 Dec; 32(12):1388-90. PubMed ID: 24569311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Case Report.
    Myers CM; Miller JJ; Davis WD
    Adv Emerg Nurs J; 2020; 42(2):108-118. PubMed ID: 32358426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Clobazam.
    Manyas H; Paketci C; Okur D; Bayram E; Hiz S; Yis U
    Pediatr Emerg Care; 2020 Mar; 36(3):e175. PubMed ID: 30870346
    [No Abstract]   [Full Text] [Related]  

  • 9. Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Kurata M; Horie C; Kano Y; Shiohara T
    Br J Dermatol; 2016 Mar; 174(3):681-3. PubMed ID: 26412450
    [No Abstract]   [Full Text] [Related]  

  • 10. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child.
    Scaggs FA; Aziz MS; Palmisano EL; Mahdavinia M; Raikar SS; Logan LK
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):719-721. PubMed ID: 28073704
    [No Abstract]   [Full Text] [Related]  

  • 11. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Rash with Eosinophilia and Systemic Symptoms: Captropril, an Unusual Culprit Drug.
    Ammar H; Chaabane A; Ben Fadhel N; Chadli Z; Ben Fredj N; Aouam K
    Dermatitis; 2019; 30(3):238-239. PubMed ID: 31045940
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico.
    Matta JM; Flores SM; Cherit JD
    An Bras Dermatol; 2017; 92(1):30-33. PubMed ID: 28225953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reaction with eosinophilia and systemic symptoms syndrome caused by an everolimus-eluting stent.
    Bianchi L; Caraffini S; Lisi P
    Int J Dermatol; 2014 Apr; 53(4):e286-8. PubMed ID: 23967898
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug reaction with eosinophilia and systemic symptoms syndrome induced by benznidazole.
    Moreno-Escobosa C; Cruz-Granados S
    Contact Dermatitis; 2018 Aug; 79(2):105-106. PubMed ID: 29635801
    [No Abstract]   [Full Text] [Related]  

  • 16. High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection.
    Mille B; Ingen-Housz-Oro S; De Prost N; Voiriot G; Soria A; Tetart F; Bernier C; Morice C; Staumont-Salle D; Dezoteux F;
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e256-e257. PubMed ID: 34927763
    [No Abstract]   [Full Text] [Related]  

  • 17. Eosinophilia and systemic symptoms with transient ageusia: a drug reaction caused by zonisamide.
    Adachi R; Kono M; Takeichi T; Muro Y; Akiyama M
    Eur J Dermatol; 2018 Aug; 28(4):523-524. PubMed ID: 29976544
    [No Abstract]   [Full Text] [Related]  

  • 18. Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.
    Zuelgaray E; Domont F; Peiffer-Smadja N; Saadoun D; Cacoub P
    Ann Intern Med; 2017 Jul; 167(2):141-142. PubMed ID: 28531906
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythema multiforme-like drug reaction with eosinophilia and systemic symptoms (DRESS).
    Hoshina D; Furuya K; Okita I
    Clin Exp Dermatol; 2015 Jun; 40(4):455-6. PubMed ID: 25545118
    [No Abstract]   [Full Text] [Related]  

  • 20. Probable Griseofulvin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms in a Child.
    Smith RJ; Boos MD; McMahon P
    Pediatr Dermatol; 2016 Sep; 33(5):e290-1. PubMed ID: 27397873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.